Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study.

Autor: Cortelezzi, A.1,2 agostino.cortelezzi@unimi.it, Pasquini, M. C.2, Gardellini, A.2, Gianelli, U.3, Bossi, A.4, Reda, G.2, Sarina, B.5, Musto, P.6, Barcellini, W.7, Neri, A.1,2, Deliliers, G. L.1,2
Zdroj: Leukemia (08876924). Nov2009, Vol. 23 Issue 11, p2027-2033. 7p. 4 Charts, 1 Graph.
Databáze: Academic Search Ultimate